John T Henderson Cytokinetics Inc (CYTK) insider trading activity

John T Henderson is Director of CYTOKINETICS INC. Currently has a direct ownership of 73,681 shares of CYTK, which is worth approximately $2.55 Million. The most recent transaction as insider was on Oct 03, 2022, when has been sold 391 shares (Common Stock) at a price of $51.11 per share, resulting in proceeds of $19,984. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.7K

50.41% 3M change

93.6% 12M change

Total Value Held $2.55 Million

JOHN T HENDERSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2022	BUY Grant, award, or other acquisition	$19,984 $51.11 p/Share	391 Added 1.57%	24,440 Common Stock
Sep 12 2022	SELL Open market or private sale	$1,195,439 $54.94 p/Share	21,759 Reduced 47.5%	24,049 Common Stock
Sep 12 2022	BUY Exercise of conversion of derivative security	$87,471 $4.02 p/Share	21,759 Added 41.0%	31,308 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	$19,967 $41.0 p/Share	487 Added 1.98%	24,049 Common Stock
May 10 2022	BUY Grant, award, or other acquisition	-	5,000 Added 17.51%	23,562 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	$18,729 $38.38 p/Share	488 Added 2.56%	18,562 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$22,746 $5.46 p/Share	4,166 Added 18.73%	18,074 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	$11,224 $46.0 p/Share	244 Added 1.78%	13,499 Common Stock
Nov 05 2021	SELL Open market or private sale	$340,120 $40.0 p/Share	8,503 Reduced 39.08%	13,255 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	$49,998 $5.88 p/Share	8,503 Added 28.1%	21,758 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	$11,242 $36.74 p/Share	306 Added 2.26%	13,255 Common Stock
Jul 07 2021	BUY Grant, award, or other acquisition	$1,246 $19.77 p/Share	63 Added 0.48%	12,949 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	$9,986 $20.98 p/Share	476 Added 3.56%	12,886 Common Stock
May 12 2021	BUY Grant, award, or other acquisition	-	5,000 Added 28.72%	12,410 Common Stock
Apr 01 2021	SELL Open market or private sale	$78,459 $23.54 p/Share	3,333 Reduced 31.02%	7,410 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$28,797 $8.64 p/Share	3,333 Added 28.14%	8,510 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	$9,995 $19.56 p/Share	511 Added 26.6%	1,410 Common Stock
Dec 31 2020	SELL Open market or private sale	$17,426 $20.31 p/Share	858 Reduced 48.83%	899 Common Stock
Dec 31 2020	BUY Exercise of conversion of derivative security	$11,120 $12.96 p/Share	858 Added 32.81%	1,757 Common Stock
Oct 05 2020	SELL Open market or private sale	$87,000 $29.0 p/Share	3,000 Reduced 76.94%	899 Common Stock
Oct 05 2020	BUY Exercise of conversion of derivative security	$38,880 $12.96 p/Share	3,000 Added 55.57%	2,399 Common Stock

JTH

John T Henderson

Director

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account